Anthropic sets up biology lab for hands-on research

Anthropic has established a biology research lab in the San Francisco Bay Area where it conducts physical, hands-on experiments, according to a Reuters report. Eric Kauderer-Abrams, the company's Head of Life Sciences, confirmed the lab exists, explaining that real lab work remains, and will remain for some time, the ultimate test in biological research. He said Anthropic is already carrying out such work both internally and through partnerships with outside organizations.

Kauderer-Abrams did not specify the lab's exact research focus, but noted that Anthropic launched a drug discovery initiative called Claude Science back in June, aimed at exploring treatments that pharmaceutical companies typically avoid because they are unlikely to be financially profitable. However, a company spokesperson told Reuters that the new lab was not created solely, or even primarily, for drug discovery purposes.

AI's role in experiments

Kauderer-Abrams said he believes artificial intelligence could help speed up the discovery of treatments for conditions long considered too difficult to address, including accelerating development of complex, targeted therapies. Sources told Reuters that one avenue Anthropic is exploring is using its Claude models to control robots that carry out scientific experiments. Still, Kauderer-Abrams stressed that the company is in the very early stages of automating lab work execution with AI, and that human oversight remains essential for safety at this point. He added that Anthropic has not yet conducted any clinical trials.

Reuters noted that Anthropic, like other AI companies, continues to face public trust concerns. The company recently disclosed that it had identified and blocked several scientists attempting to use its AI models to develop potential biological weapons. Anthropic CEO Dario Amodei has previously called for slowing the pace of advanced AI development to reduce the risk of losing control over frontier systems.